Latest news
Almirall taps CrystalO's AI platform to discover ion channel drugs for skin disease - AllSciAllSci · Mon, 10 Aug 2026 16:51:48 GMTSobi funds Innate's phase III lacutamab trial with USD 75 million upfront deal - AllSciAllSci · Mon, 10 Aug 2026 16:50:24 GMTTenax’s levosimendan fails Phase III LEVEL trial in PH-HFpEF - AllSciAllSci · Mon, 10 Aug 2026 16:40:47 GMTBeOne and Revolution Medicines partner on RAS(ON) inhibitor combinations in Asia - AllSciAllSci · Mon, 10 Aug 2026 16:11:22 GMTGRAIL’s Galleri becomes first multi-cancer detection test headed to US FDA advisory panel - AllSciAllSci · Mon, 10 Aug 2026 14:39:13 GMTAcurx and Leiden University Medical Center target first inhibitor-bound MRSA PolC structure - AllSciAllSci · Mon, 10 Aug 2026 14:22:58 GMTJazz moves on Actio Bio for up to USD 1.3b to enter KCNT1-driven epilepsy market - AllSciAllSci · Mon, 10 Aug 2026 13:57:16 GMTUS bill could subject China-to-US pharma licensing deals to national security controls - AllSciAllSci · Mon, 10 Aug 2026 12:39:37 GMT